Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 5 January 2026 - 6 January 2026

Micron stock jumps 5% on Gen5 SSD launch as memory-price surge stays in focus

Micron stock jumps 5% on Gen5 SSD launch as memory-price surge stays in focus

New York, Jan 6, 2026, 09:49 EST — Regular session Micron Technology, Inc. shares rose about 5% in early New York trading on Tuesday after the memory-chip maker announced a new client solid-state drive. The stock was up 5.2% at $328.27, versus a 1.7% rise for the iShares Semiconductor ETF, after closing at $312.15 on Monday. Micron said it launched the Micron 3610, a client SSD it described as the first PCIe Gen5 drive using its G9 QLC NAND — a denser type of flash storage designed to lower cost per bit. Micron said the drive can reach sequential read
6 January 2026
·····
Zenas BioPharma stock slides again premarket after INDIGO Phase 3 data sparks fresh scrutiny

Zenas BioPharma stock slides again premarket after INDIGO Phase 3 data sparks fresh scrutiny

New York, January 6, 2026, 08:44 EST — Premarket Zenas BioPharma (ZBIO.O) shares were down 5.8% at $15.66 in premarket trading on Tuesday after ending Monday down 51.9% at $16.61. MarketScreener The slide follows a late-stage readout for the company’s lead drug obexelimab in IgG4-related disease (IgG4-RD), a rare immune condition that can inflame and scar organs. Zenas met the main goal, but Wedbush analyst Martin Fan said investors were looking for a stronger effect than the hazard ratio of 0.44, a measure of risk over time where lower is better. Amgen’s Uplizna, the only FDA-approved treatment for IgG4-RD, cut
6 January 2026
·····
Microsoft stock flat after Osmos buy as investors eye Fabric push and key U.S. data

Microsoft stock flat after Osmos buy as investors eye Fabric push and key U.S. data

New York, January 6, 2026, 09:36 EST — Regular session Microsoft shares were down 4 cents at $472.85 in early trading on Tuesday. The stock move followed Microsoft’s purchase of Seattle-based startup Osmos, a deal aimed at automating parts of data engineering inside Microsoft Fabric, its data and analytics platform. Terms were not disclosed, GeekWire reported. GeekWire The timing matters for investors because large-cap growth stocks have traded closely to shifts in interest-rate expectations, and traders are scanning incoming U.S. data for clues on the Federal Reserve’s next steps. Richmond Fed President Tom Barkin said on Tuesday the central bank
6 January 2026
····
Hut 8 stock slips before the bell after a 14% jump — what traders watch next for HUT

Hut 8 stock slips before the bell after a 14% jump — what traders watch next for HUT

New York, January 6, 2026, 09:04 EST — Premarket Hut 8 Corp shares eased 0.4% in premarket trading on Tuesday to $58.01, after the bitcoin miner and data-center operator surged 13.6% on Monday to close at $58.25. Bitcoin was up 1.1% at $93,709. Nasdaq The move matters because crypto-linked equities have started 2026 tethered to shifts in digital-asset sentiment and rates expectations. Filings with the U.S. Securities and Exchange Commission on Tuesday showed Morgan Stanley is seeking approval to launch exchange-traded funds tied to bitcoin and solana — listed products that track an asset’s price and trade like a stock.
6 January 2026
········
AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

NEW YORK, Jan 6, 2026, 08:02 EST — Premarket AbbVie shares were flat in premarket trading on Tuesday after the drugmaker said Health Canada had approved its hepatitis C pill Maviret for both acute and chronic infection. AbbVie stock last traded at $220.18. The expanded label matters because it opens the door to treatment soon after diagnosis, when infections are recent and transmission risk can be higher. The company said the eight-week, pan-genotypic regimen — meaning it works across major virus types — is now cleared in Canada for acute and chronic hepatitis C virus (HCV). AbbVie fell 3.98% on
6 January 2026
···
Brazil stock market today: Oil shock, Ibovespa reshuffle and a CEO switch to watch before the B3 bell

Brazil stock market today: Oil shock, Ibovespa reshuffle and a CEO switch to watch before the B3 bell

Sao Paulo, Jan 6, 2026, 06:55 BRT — Premarket Brazil’s benchmark Ibovespa heads into Tuesday’s open near recent highs after closing up 0.83% at 161,869.76 points, as investors weighed Venezuela-related geopolitical risk against firmer commodities. Bora Investir Why it matters now: the index is heavily tilted toward banks and commodity-linked names, so swings in crude and iron ore can quickly set the tone for the whole tape. That sensitivity is amplified this week by portfolio rebalancing tied to the new Ibovespa composition. Bora Investir+1 Rate expectations are the other pressure point. Brazil’s “Focus” survey — the central bank’s weekly compilation
6 January 2026
····
Shell stock in focus after buyback update as oil slips ahead of Jan. 8 quarterly release

Shell stock in focus after buyback update as oil slips ahead of Jan. 8 quarterly release

NEW YORK, Jan 6, 2026, 03:16 (EST) — Market closed Shell Plc said it bought back about 1.5 million shares on Jan. 5 in London and Amsterdam, paying between £27.22 and £27.94 in London and €31.445 to €32.185 in Amsterdam. Its U.S.-listed shares (SHEL) closed down 0.54% at $75.03 on Monday. GlobeNewswire The transaction keeps attention on shareholder returns as Shell heads into a quarterly update due on Jan. 8, ahead of its fourth-quarter results on Feb. 5, when it will also announce an interim dividend. Shell That timing matters because the oil tape has turned jumpy again, and the
6 January 2026
······
Adobe stock slips on Jefferies downgrade as AI payoff questioned — what to watch next

Adobe stock slips on Jefferies downgrade as AI payoff questioned — what to watch next

New York, Jan 5, 2026, 20:40 EST — Market closed Adobe (ADBE.O) shares slipped on Monday after Jefferies downgraded the Photoshop maker to “hold,” arguing that the company’s push to monetise new artificial intelligence tools is not yet translating into faster growth. The stock ended down 0.5% at $331.56. Investing.com The downgrade matters now because investors are re-pricing software stocks around a simple question: will generative AI add incremental subscription revenue, or pressure the value of traditional application licences? For Adobe, which has leaned on Creative Cloud subscriptions for years, that debate is moving from product demos to revenue math.
6 January 2026
······
Walmart stock: Mizuho lifts target but drops WMT from top picks as Feb. 19 earnings loom

Walmart stock: Mizuho lifts target but drops WMT from top picks as Feb. 19 earnings loom

New York, Jan 5, 2026, 20:03 EST — Market closed Walmart Inc shares were last at $112.71 after U.S. markets shut, little changed in late after-hours trading. The muted move masks a bigger question hanging over big-box retail at the start of 2026: whether spending holds up as inflation remains elevated and the labor market shows signs of cooling. For Walmart, that debate matters because it sits at the intersection of grocery essentials and discretionary categories. Investors tend to treat it as both a consumer bellwether and a defensive name when households tighten budgets. In Monday’s regular session, Walmart closed
6 January 2026
·····
Micron stock whipsaws as “unprecedented” AI memory shortage tightens supply

Micron stock whipsaws as “unprecedented” AI memory shortage tightens supply

New York, Jan 5, 2026, 16:09 EST — After-hours Micron Technology Inc (MU) closed down 3.68 points, or about 1.2%, at $311.74 on Monday after a volatile session that saw the stock trade between $309.60 and $328.44. The chipmaker opened at $325 versus Friday’s close of $315.42, with volume near 30.7 million shares. The late fade matters because Micron has become a high-beta gauge of how far the AI buildout can push memory pricing. After a steep run, traders have been quicker to lock in gains, even on broadly constructive sector headlines. Investors are also debating whether the memory upturn
5 January 2026
·····
NVIDIA stock slips after close as Huang’s CES 2026 keynote puts NVDA roadmap under the microscope

NVIDIA stock slips after close as Huang’s CES 2026 keynote puts NVDA roadmap under the microscope

New York, January 5, 2026, 4:09 PM EST — After-hours NVIDIA Corporation shares ended lower on Monday as investors turned to Chief Executive Jensen Huang’s CES keynote for fresh signals on the chipmaker’s product roadmap and demand outlook. The stock closed down 0.6% at $187.75, with after-hours trading under way after the 4 p.m. EST close. The moment matters because CES is the first major technology showcase of the year, and NVIDIA sits at the center of AI infrastructure spending. Traders have treated management commentary as a high-frequency readout on whether demand for the company’s newest chips is keeping pace
5 January 2026
····
BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

New York, January 5, 2026, 14:30 (EST) — Regular session BridgeBio Pharma shares slid 7.5% to $72.34 in afternoon trading on Monday after opening at $78.44 and touching $79.24 earlier in the session. The drop outpaced a roughly 2.2% decline in the SPDR S&P Biotech ETF, a broad gauge of U.S. biotech stocks. The move lands just ahead of a dense stretch of biotech investor events that can reshape positioning at the start of the year. For BridgeBio, the calendar puts fresh focus on a late-stage growth program and the company’s next set of talking points on its commercial heart
5 January 2026
·····
1 … 68 69 70 71 72 … 282

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop